| pubmed-article:17891059 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17891059 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17891059 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:17891059 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17891059 | lifeskim:mentions | umls-concept:C0271084 | lld:lifeskim |
| pubmed-article:17891059 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:17891059 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:17891059 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17891059 | pubmed:dateCreated | 2008-1-17 | lld:pubmed |
| pubmed-article:17891059 | pubmed:abstractText | To evaluate 6- and 9-month follow-up data including the effect on vision and anatomic outcome in patients treated with intravitreal bevacizumab for neovascular age-related macular degeneration (AMD). | lld:pubmed |
| pubmed-article:17891059 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891059 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17891059 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891059 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17891059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891059 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17891059 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17891059 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17891059 | pubmed:issn | 0950-222X | lld:pubmed |
| pubmed-article:17891059 | pubmed:author | pubmed-author:Hickey-DwyerM... | lld:pubmed |
| pubmed-article:17891059 | pubmed:author | pubmed-author:AchesonR WRW | lld:pubmed |
| pubmed-article:17891059 | pubmed:author | pubmed-author:RavikumarKK | lld:pubmed |
| pubmed-article:17891059 | pubmed:author | pubmed-author:KelliherCC | lld:pubmed |
| pubmed-article:17891059 | pubmed:author | pubmed-author:JungkimSS | lld:pubmed |
| pubmed-article:17891059 | pubmed:author | pubmed-author:ClearyC ACA | lld:pubmed |
| pubmed-article:17891059 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17891059 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:17891059 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17891059 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17891059 | pubmed:pagination | 82-6 | lld:pubmed |
| pubmed-article:17891059 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:meshHeading | pubmed-meshheading:17891059... | lld:pubmed |
| pubmed-article:17891059 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:17891059 | pubmed:articleTitle | Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results. | lld:pubmed |
| pubmed-article:17891059 | pubmed:affiliation | Department of Ophthalmology, Mater Misericordiae Hospital, Dublin, Ireland. ucclearly@mac.com | lld:pubmed |
| pubmed-article:17891059 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17891059 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:17891059 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17891059 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17891059 | lld:pubmed |
